Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer

Key Points

• The study investigates the clinician- and facility-level factors that influence chemotherapy dose reductions in patients with stages I-IIIA breast cancer.
• Analyzed clinician and facility characteristics affecting chemotherapy practices
• Assessed impact of practice size and patient volume on dosing
• Evaluated patterns of dose reductions in treatment regimens
• Identified significant associations between larger practice sizes and reduced dose adjustments
• Found that increased patient volume positively influences optimal dosing decisions
• Highlighted variability in practices across different facilities